weight loss drug news today glp-1 october 2025 obesity How Supply and Demand for Drugs is Playing Out in 2026 GLP-1 Pipeline Update: August 2025

The NHPs were single-housed just before dosing until approximately 12 h after dosing

If considering weight loss medication, it helps to understand the factors influencing your weight

While most current medications target one or two hormones, Retatrutide is a triple-agonist meaning it works on three metabolic pathways at once: GLP-1: curbs appetite and helps you eat less GIP: supports nutrient utilization and lean muscle metabolism Glucagon: boosts fat burning and overall energy expenditure In short, it doesnt just help you eat less it helps your body burn more and keep muscle while losing fat

Lancet 357, 354357

Previous research has shown conflicting results regarding correlation between GLP-1 medications and thyroid function

Fang M, Jeon Y, Echouffo-Tcheugui JB, Selvin E (2023) Prevalence and management of obesity in U.S